News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Minai-Azary Jennifer Lynn
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
4
| Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 158,001 options to buy
@ $0.8407, valued at
$132.8k
|
|
| 12/19/2022 |
4
| Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 25,000 shares
@ $0.74, valued at
$18.5k
|
|
| 08/17/2022 |
4
| Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 15,000 shares
@ $1.8, valued at
$27k
|
|
| 02/25/2022 |
4
| Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 112,470 options to buy
@ $1.79, valued at
$201.3k
|
|
| 11/01/2021 |
4
| Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 52,753 options to buy
@ $5.59, valued at
$294.9k
|
|
| 11/01/2021 |
3
| Minai-Azary Jennifer Lynn (CFO) has filed a Form 3 on Context Therapeutics Inc. |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
3
| Minai-Azary Jennifer Lynn (CFO) has filed a Form 3 on Millendo Therapeutics, Inc. |
|
|